Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/3/23 16:39 | 11/1/23 | EGRX | Health | Drug | Pharmaceutical Preparations | Tarriff Scott | NJ | DOT | CEO | S.m | -299 | 13.84 | 0 | -22 | -1 | 1,538 | D | ||||||||||||||
10/31/23 17:41 | 10/27/23 | EGRX | Health | Drug | Pharmaceutical Preparations | Graves Michael | NJ | D | M.d | 46 | 4.94 | 0 | 9 | 936 | 10 | D | |||||||||||||||
10/4/23 17:07 | 10/2/23 | EGRX | Health | Drug | Pharmaceutical Preparations | Tarriff Scott | NJ | DOT | CEO | S.m | -300 | 14.82 | 0 | -20 | -1 | 1,560 | D | ||||||||||||||
5/18/23 17:22 | 5/16/23 | EGRX | Health | Drug | Pharmaceutical Preparations | Tarriff Scott | NJ | DOT | CEO | S | -300 | 19.98 | 0 | -15 | -1 | 1,580 | D | ||||||||||||||
5/15/23 20:34 | 5/11/23 | EGRX | Health | Drug | Pharmaceutical Preparations | Tarriff Scott | NJ | DOT | CEO | S.m | -931 | 20.68 | 0 | -45 | -3 | 1,595 | D | ||||||||||||||
9/8/22 17:08 | 9/6/22 | EGRX | Health | Drug | Pharmaceutical Preparations | Edlin Richard A. | NJ | D | S | -211 | 30.99 | 0 | -7 | -23 | 23 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |